% from lower long-term borrowing. Net debt to EBITDA (excluding lease liabilities and license payable) remained healthy at 0.8x. Total equity was at Bt85,816mn, which increased 4.9% from higher retained
acquisition resulted in increase in both asset and liabilities . Total liabilities reported Bt309,944mn, increasing +41% from lease liabilities and spectrum payable. Total equity reported Bt64,772mn decline
of Dec-21 stood at Bt87,828mn, decreasing from Bt99,600mn at ending Dec-20. Net debt to EBITDA (excluding lease liabilities and license payable) was 0.8x. Total equity reported Bt81,825mn, increasing
9/11 Summary of financial statement of Medical Vision Company Limited as of 31 December 2019 Item Value (Baht) Total Assets 25,390,781.70 Total Liabilities 22,670,829.42 Total Shareholders' Equity
49,163.2 33,100.6 82,539.6 50,979.6 31,560.0 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 Total Assets Total Liabilities Total Shareholder Equity 2019 Q2 2020 Unit: THB mm average cost of
%. Shareholders 'equity: The Company and its subsidiaries have total shareholders' equity as of June30, 2019 in the amount of (2,054.86) million Baht, a decrease of 142.34 million Baht from the previous year
(432.06) (14.96) Total shareholders' equity (1,983.26) (1,912.52) (70.74) 3.70 Book value - baht per share (0.64) (0.61) (0.03) 8.20 Note: Value of registered and paid-up shares at 1 baht per share
70,000 80,000 Total Assets Total Liabilities Total Shareholder Equity 2017 Q3 2018 Unit : THB mm sale to client of 1 project, resulting in the decrease of non-current assets held for sale by THB 835.2 mm
76,705.4 48,319.1 28,386.3 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 Total Assets Total Liabilities Total Shareholder Equity 2017 Q2 2018 Unit: THB mm 9. Decrease in other current